Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Actual shortage | 2023-07-13 | 2023-07-13 | 198514 |
APO-LISINOPRIL | 20MG | TABLET | Actual shortage | 2023-07-13 | 2024-04-05 | 198536 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-07-27 | 2024-03-15 | 200177 |
APO-ACYCLOVIR | 400MG | TABLET | Actual shortage | 2023-09-01 | 2023-09-01 | 203566 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-09-28 | 2024-03-15 | 205480 |
APO-AMITRIPTYLINE | 10MG | TABLET | Actual shortage | 2023-10-20 | 2023-10-20 | 207698 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-06 | 2024-03-15 | 209286 |
APO-DARIFENACIN | 15MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-01 | 2024-02-02 | 212368 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Actual shortage | 2023-12-08 | 2024-01-19 | 212958 |
APO-EZETIMIBE | 10MG | TABLET | Actual shortage | 2023-12-08 | 2024-01-19 | 212961 |
APO-MYCOPHENOLATE | 500MG | TABLET | Actual shortage | 2023-12-08 | 2024-01-19 | 212965 |
APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-08 | 2024-01-19 | 212969 |
APO-DARIFENACIN | 7.5MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-15 | 2024-02-02 | 213547 |
APO-LISINOPRIL | 10MG | TABLET | Actual shortage | 2023-12-15 | 2024-04-05 | 213581 |
APO-TIMOP | 0.5% | SOLUTION | Actual shortage | 2024-01-05 | 2024-05-03 | 215215 |
APO-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-01-05 | 2024-01-19 | 215247 |
APO-CARVEDILOL | 25MG | TABLET | Actual shortage | 2024-01-12 | 2024-01-12 | 215952 |
APO-CARVEDILOL | 12.5MG | TABLET | Actual shortage | 2024-01-12 | 2024-03-31 | 215955 |
APO-CABERGOLINE | 0.5MG | TABLET | Actual shortage | 2024-01-12 | 2024-05-31 | 215982 |
APO-COLESEVELAM | 625MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216646 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 |